Experimental haemophilic arthropathy in a mouse model of a massive haemarthrosis: Gross, radiological and histological changes

Haemophilia

Volumn 14, Issue 4, 2008, Pages 804-809

  Hakobyan, Narine ^a   Enockson, C ^a   Cole, A A ^a   Sumner, D R ^a   Valentino, L A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arthropathy; Haemarthrosis; Haemophilia; Model; Mouse

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; BONE ATROPHY; CARTILAGE DEGENERATION; CONTROLLED STUDY; HEMARTHROSIS; HEMOPHILIA; HISTOPATHOLOGY; IMAGE ANALYSIS; JOINT INJURY; JOINT RADIOGRAPHY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; FACTOR VIII; HEMARTHROSIS; HEMOPHILIA A; MICE; MICE, KNOCKOUT; PROTEOGLYCANS; RECOMBINANT PROTEINS; SYNOVITIS; X-RAY MICROTOMOGRAPHY;

EID: 43749088065     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01689.x     Document Type: Article

References (27)

1. Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994; 236: 391-9.
2. Centers for Disease Control and Prevention report on the Universal Data Collection Program. In: Prevention CfDCa, ed. 2005: 17.
3. Gruppo RA, Brown D, Wilkes MM, Navickis RJ. Meta-analytic evidence of increased breakthrough bleeding during prophylaxis with B-domain deleted factor VIII. Haemophilia 2004; 10: 747-50.
4. Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
5. Rodriguez-Merchan EC. Effects of hemophilia on articulations of children and adults. Clin Orthop Relat Res 1996; 328: 7-13.
6. Roosendaal G, Vianen ME, Marx JJ, van den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: A human in vitro study. Arthritis Rheum 1999; 42: 1025-32.
7. Hooiveld M, Roosendaal G, Vianen M, van den Berg M, Bijlsma J, Lafeber F. Blood-induced joint damage: Longterm effects in vitro and in vivo. J Rheumatol 2003; 30: 339-44.
8. Hooiveld M, Roosendaal G, Wenting M, van den Berg M, Bijlsma J, Lafeber F. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 2003; 162: 943-51.
9. Hooiveld MJ, Roosendaal G, van den Berg HM, Bijlsma JW, Lafeber FP. Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: An in vitro study. Rheumatology (Oxford) 2003; 42: 784-90.
10. Hooiveld MJ, Roosendaal G, Vianen ME, van den Berg HM, Bijlsma JW, Lafeber FP. Immature articular cartilage is more susceptible to blood-induced damage than mature articular cartilage: An in vivo animal study. Arthritis Rheum 2003; 48: 396-403.
11. Roosendaal G, Lafeber FP. Blood-induced joint damage in hemophilia. Semin Thromb Hemost 2003; 29: 37-42.
12. Roosendaal G, Tekoppele JM, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Articular cartilage is more susceptible to blood induced damage at young than at old age. J Rheumatol 2000; 27: 1740-4.
13. Tan AH, Mitra AK, Chang PC, Tay BK, Nag HL, Sim CS. Assessment of blood-induced cartilage damage in rabbit knees using scanning electron microscopy. J Orthop Surg (Hong Kong) 2004; 12: 199-204.
14. Muirden K. Iron in the synovial membrane in rheumatoid arthritis and other joint diseases. Univ Mich Med Cent J 1968; 1: 281-2.
15. Wen FQ, Jabbar AA, Chen YX, Kazarian T, Patel DA, Valentino LA c-myc proto-oncogene expression in hemophilic synovitis: In vitro studies of the effects of iron and ceramide. Blood 2002; 100: 912-6.
16. Valentino LA, Hakobyan N, Kazarian T, Jabbar KJ, Jabbar AA. Experimental haemophilic synovitis: Rationale and development of a murine model of human factor VIII deficiency. Haemophilia 2004; 10: 280-7.
17. Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH, Jr. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 1995; 10: 119-21.
18. Bi L, Sarkar R, Naas T, et al. Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood 1996; 88: 3446-50.
19. Lin HF, Maeda N, Smithies O, Straight DL, Stafford DW. A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 1997; 90: 3962-6.
20. Valentino LA. Secondary prophylaxis therapy: What are the benefits, limitations and unknowns? Haemophilia 2004; 10: 147-57.
21. Benedetto KP, Glotzer W. [Hemarthrosis of the knee joint Differential diagnosis]. ZFA (Stuttgart) 1982; 58: 1591-3.
22. Bachmann G, Jurgensen I, Leiers S, Rauber K. [MRI in hemarthrosis of the knee joint: Assessment of cause of bleeding, injury pattern and therapy]. Rofo 1996; 165: 270-5.
23. Bennett RM, Williams ED, Lewis SM, Holt PJ. Iron accumulation in rheumatoid knees. Clin Sci 1972; 43: 11P-2P.
24. Bennett RM, Williams ED, Lewis SM, Holt PJ. Synovial iron deposition in rheumatoid arthritis. Arthritis Rheum 1973; 16: 298-304.
25. Nilsonne U, Moberger G. Pigmented villonodular synovitis of joints. Histological and clinical problems in diagnosis. Acta Orthop Scand 1969; 40: 448-60.
26. Ahlberg A. Haemophilia in Sweden VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthop Scand 1965; 77: 3-132.
27. Brackmann HH, Eickhoff HJ, Oldenburg J, Hammerstein U. Long-term therapy and on-demand treatment of children and adolescents with severe haemophilia A: 12 years of experience. Haemostasis 1992; 22: 251-8.